RedStone: Oracle infrastructure launches on Filecoin mainnet - 22 Oct 2026

RedStone launched its oracle data infrastructure on Filecoin mainnet, starting with a FIL/USD price feed. The feed updates every 0.5% price move or at least every four hours, providing FIL's onchain dollar price to Filecoin Virtual Machine smart contracts.

Original reporting
Published Oct 22, 2026, 8:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 8:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RedStone: Oracle infrastructure launches on Filecoin mainnet - 22 Oct 2026 — source image
Decision brief

The 30-second read

$FIL-USDBullishLow
01

Why it matters

The launch introduces a new price feed, potentially improving market confidence in FIL pricing.

02

Market read

Adds a data layer to Filecoin, modestly supportive for FIL traders.

03

What to watch

Potential competition from other oracle providers could dilute impact.

Relevance 5/10Novelty 6/10Timing: immediate

Background

RedStone is a provider of real‑world data feeds for blockchain applications.

Company-level read

Ticker impact

$FIL-USDBullishMedium confidence
Context

RedStone launched an oracle feed on Filecoin mainnet providing on‑chain FIL/USD price updates.

Expected impact

likely modest upside as traders gain reliable price data

Evidence & confidence

First‑time oracle integration adds utility, but scale is limited.

Market effects

enhances data infrastructure for decentralized finance on Filecoin

primarily affects crypto markets globally

limited to blockchain and oracle ecosystem participants

Counterpoint

Oracle addition may not drive significant FIL price movement if adoption is slow.

Key entities

  • RedStone

    Oracle data provider launching on Filecoin.

  • Filecoin

    Decentralized storage network whose native token is FIL.

Related articles

$GOOGLMedAI 8/10

Key facts: Alphabet raises AI capex; Search slows; FCF turns negative

Alphabet (GOOGL) plans $195–$205B in 2026 capital spending, mainly on AI, with higher investment expected in 2027. Q3 free cash flow turned negative at -$9.1B. Google Search revenue grew 12% in Q3, down from 17% in Q2. Alphabet seeks to sell its Tensor Processing Units to customers like Meta. Shares rose 3% after raising C$6B in Canadian bonds.

$AVGOMedAI 8/10

VMware vCenter: Critical Zero-Day Vulnerability Actively

Broadcom disclosed a critical zero-day vulnerability (CVE-2026-123890) in VMware vCenter Server, with a CVSS score of 9.8. The flaw allows attackers to bypass authentication and gain admin privileges. The vulnerability was exploited in targeted attacks since September 2026 by the group ARMORY CASTLE. Broadcom released security updates for affected products, including vCenter 8.0, 9.0, and 9.1. Affected organizations are urged to take immediate action as there is no official workaround.

$SLSMed

An Off-the-Shelf Vaccine Could Give Doctors a New Tool Against Leukemia

Sellas Life Sciences and Memorial Sloan Kettering Cancer Center reported that the experimental leukemia vaccine, galinpepimut-S (GPS), reduced the risk of death by 41% in a Phase 3 trial. The vaccine, tested on 126 patients with acute myeloid leukemia (AML) in remission, showed a median overall survival of 24 months compared to 14.7 months with other treatments. Sellas plans to discuss regulatory approval with the FDA and submit a Biologics License Application in 2027.

$GOOGMedAI 8/10

Google’s expansion puts Wyoming’s data center debate in focus

Google plans a $17 billion data center in Wyoming, committing to cover electricity costs and using air cooling to reduce water use. The project includes a 702-MW fuel cell facility powered by natural gas, with carbon capture technology. Local residents have raised concerns about resource use and long-term impacts, while Google estimates hundreds of millions in property tax revenue for the area. Construction is expected to take several years, with full operation by 2028.

$MRNAMedAI 8/10

A study in JAMA Network Open found Moderna's mRNA-1283 vaccine reduced medically attended COVID-19 risk by 35.9% and…

A study in JAMA Network Open found Moderna's mRNA-1283 vaccine reduced medically attended COVID-19 risk by 35.9% and hospitalization risk by 47.0% compared to Pfizer/BioNTech's BNT162b2 in older veterans during the 2025-2026 season. The study included 294,499 participants, with mRNA-1283 showing better outcomes across various metrics. Moderna supported the study, which was conducted by independent investigators.